semaglutide and inflammation reduction does decrease Quantifying the Anti-Inflammatory Effects of GLPs: New Study Findings semaglutide inflammation semaglutide – Weight Loss Injections for Chronic

Type 2 Diabetes, Non-Alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease (CVD), and the Potential of Microbial Therapeutics

This is when the psychological shift begins, where food stops being a constant mental presence

TrumpRx, a federal purchasing portal announced November 2025 and launching January 2026, uses the threat of 100% tariffs on pharmaceutical imports to force Novo Nordisk, Eli Lilly, and other manufacturers into Most Favored Nation pricing agreements that bring GLP-1 injectables down to ~$350/month for cash-pay users, bypassing the insurance, PBM, and traditional pharmacies & competing directly with Ro by redirecting patients who search for drugs on TrumpRx.gov to the same manufacturer cash-pay pharmacies Ro pipes into

is listed as an inventor on a patent application on the therapeutic uses of Lb NOX and TPNOX (US patent application US20190017034A1)